Also trades as: MBX.TO (TSX) · $vol 0M
MBXBF OTC
Microbix Biosystems Inc.
1W: +2.8%
1M: +2.8%
3M: +3.2%
YTD: +26.9%
1Y: +18.5%
3Y: -17.2%
5Y: -46.5%
$0.22
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$80K
-101.8% ▼
Capital Expenditures
$798K
+58.1% ▲
5Y CAGR: -0.4%
Free Cash Flow
-$879K
-136.0% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$2M
-87.3% ▼
Net Change in Cash
-$1M
-190.8% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $3M | $2M | -$39K | $4M | -$2M |
| Depreciation & Amort. | $822K | $1M | $1M | $2M | $2M |
| Stock-Based Comp. | $378K | $650K | $735K | $714K | $650K |
| Change in Working Capital | -$3M | -$340K | -$220K | -$2M | -$759K |
| Other Non-Cash Items | $892K | $331K | -$3M | $274K | $246K |
| Operating Cash Flow | $2M | $3M | -$1M | $4M | -$80K |
| — Investing Activities — | |||||
| Capital Expenditures | -$1M | -$2M | -$1M | -$2M | -$1M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $680K | $0 | $0 | -$271K | $202K |
| Investing Cash Flow | -$622K | -$2M | -$1M | -$2M | -$798K |
| — Financing Activities — | |||||
| Net Debt Issuance | $84K | -$1M | $1M | -$522K | -$849K |
| Stock Repurchased | $0 | $0 | -$1M | -$925K | -$2M |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $2M | $3M | $105K | $364K | -$211K |
| Financing Cash Flow | $8M | $2M | $229K | -$1M | $27K |
| Net Change in Cash | $10M | $4M | -$2M | $1M | -$1M |
| Cash End of Period | $10M | $13M | $12M | $13M | $12M |
| Free Cash Flow | $804K | $1M | -$2M | $2M | -$879K |